Protocol Details

Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number	90-DK-0137
Sponsoring Institute	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruitment Detail	Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 18 Max Age: 100
Referral Letter Required	Yes
Population Exclusion(s)	Children
Keywords	Zollinger-Ellison Syndrome; Natural History
Recruitment Keyword(s)	None
Condition(s)	Zollinger Ellison Syndrome
Investigational Drug(s)	None
Investigational Device(s)	None
Intervention(s)	None
Supporting Site	National Institute of Diabetes and Digestive and Kidney Diseases

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).

Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.

--Back to Top--

Citations:

Zollinger-Ellison syndrome: current concepts in diagnosis and management

Current diagnosis and management of Zollinger-Ellison syndrome

Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)

--Back to Top--

Contacts:

Principal Investigator	Referral Contact	For more information:
Robert T. Jensen, M.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health Building 10 Room 9C103 10 Center Drive Bethesda, Maryland 20892 (301) 496-4201 robertj@bdg10.niddk.nih.gov	Stephen A. Wank, M.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIHBC 10 - CLINICAL CENTER BG RM 9C101 10 CENTER DR BETHESDA MD 20892 (301) 496-4202 stevew@mail.nih.gov	Office of Patient Recruitment National Institutes of Health Clinical Center (CC) Building 61, 10 Cloister Court Bethesda, Maryland 20892 Toll Free: 1-800-411-1222 Local Phone: 301-451-4383 TTY: TTY Users Dial 7-1-1 ccopr@nih.gov

Clinical Trials Number:

NCT00001254

--Back to Top--